Health Care: Drugs

Actavis PLC (ACT: NYSE)

$295.41 n/a | n/a%
04/24/15 - 04:01 PM ET
Company Profile
Price and Volume
Recent Price 297.05
52 Week High 317.72
52 Week Low 193.00
Avg. Daily Vol. (Mil) 3.34
Beta (3 year) 0.78
Share Related Items
Mkt Cap (Mil) 79,090.24
Shares Out (Mil) 266.25
Float (Mil) 173.71
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 0.50
Current Ratio 1.40
LT Debt/ Equity 0.52
Total Debt / Equity 0.55
Valuation Ratios
Price Earnings n.a.
Price/Sales 6.05
Price/Book 2.79
Price/Cash Flow 34.50
Per Share Data
Earnings -7.42
Sales 49.06
Book Value 106.41
Cash Flow 8.61
Business Summary
Actavis PLC specialty pharmaceutical company engaged in developing, manufacturing and distributing generic, brand and biosimilar products.
General Information
1 Grand Canal Square
Docklands
Dublin, 2
www.actavis.com
Industry : Drugs
Sector: Health Care
Employees: 21600
CEO: Mr. Brenton L. Saunders
Short Interest
Current Month (Mil) 7.18
Previous Month (Mil) 26.27
Short Interest Ratio (Days) 2.00
Management Effectiveness
Return on Equity n.a.
Return on Assets -3.10
Return on Investments -3.80
Profitability
Gross Margin 61.90
EBIT Margin -10.00
Profit Margin -12.50

Portfolios with ACT

Latest ACT Headlines from TheStreet

More Financial News for ACT

Press Releases for ACT

See All Press Releases

Partner Headlines for ACT

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter